MedBright AI Investments Inc (QB) (MBAIF) Quote

Rejuvenation Medical Group is using MBAI's MedMatrix AI Platform to enhance its clinic operations, displaying MBAI's partnering capability & MedMatrix's scalability. This advanced AI tech offers data reporting, forecasting & more, aiding clinic revenue growth while improving patient experience.
https://www.reddit.com/r/ArtificialInteligence/duplicates/1bkksog/medbright_ai_investments_inc_mbaic_enhances/

The renowned Canadian medical group, Rejuvenation, is integrating MBAI.c's MedMatrix AI Reporter to enhance its clinic operations. This advanced AI tech streamlines reporting, optimizes resources, and is expected to boost revenue.
https://financialpost.com/globe-newswire/rejuvenation-medical-group-of-canada-uses-medmatrix-ai-reporter-to-streamline-reporting-and-improve-operations

MedBright AI CEO Trevor Vieweg sits down with Penny Queen to talk about how their AI Platform can optimize clinic schedules, boost revenue and enhance patient care

Today, MedBright AI (MBAI.c MBAIF) announced the further expansion of its MedMatrix AI Platform with the adoption of its commercial platform in 8 of clinics spread across 3 Canadian Provinces and comprising of 21 dermatologists, 5 Mohs surgeons, 3 plastic surgeons and 13 general practitioners specializing in dermatology: https://www.globenewswire.com/news-release/2024/03/19/2848510/0/en/Rejuvenation-Medical-Group-of-Canada-uses-MedMatrix-AI-Reporter-to-Streamline-Reporting-and-Improve-Operations.html

The market size for AI in healthcare is forecasted to grow at a 37% CAGR through 2030, driven by the integration of AI technologies for improved patient care, early disease detection, and management of vast patient data amidst growing digitalization in healthcare.$NVDA $AMD… pic.twitter.com/uOxm1twdtA— Beth Kindig (@Beth_Kindig) March 18, 2024

MedBright's MedMatrix (MBAI.c) AI Platform optimizes operations, expands strategically, and boosts revenue. With a suite of advanced features, including AI Market Expander, it aids DISCC's expansion in Southern California, promising swift scalability.

In targeting a revolution in outpatient clinical services, MedBright AI (MBAI.c MBAIF) and its MedMatrix Platform is well positioned as the market size for AI in healthcare is forecasted to grow at a 37% CAGR through 2030: The market size for AI in healthcare is forecasted to grow at a 37% CAGR through 2030, driven by the integration of AI technologies for improved patient care, early disease detection, and management of vast patient data amidst growing digitalization in healthcare.$NVDA $AMD… pic.twitter.com/uOxm1twdtA— Beth Kindig (@Beth_Kindig) March 18, 2024

The title "How Artificial Intelligence Is Empowering Advanced Analytics and Revolutionizing Outpatient Clinical Services" says it all - this is a must-read post for anyone interested in investing in early-stage broadly applicable AI technology: https://www.reddit.com/r/SwaggyStocks/comments/1bfpnog/how_artificial_intelligence_is_empowering/

MBAI is rolling out a full version of MedMatrix, an AI platform for optimized outpatient facility mgmt. The platform is set to optimize clinic expansion for the DISCC clinic group, further highlighting its rapid scalability. With AI-driven features, MedMatrix is expected to create a 10% revenue increase for clinics sans extra costs to them.Details here⬇️
https://financialpost.com/globe-newswire/southern-california-clinic-uses-medmatrix-ai-market-expander-to-launch-opening-of-new-clinic-locations

This video explores AI's impact on cancer treatment and healthcare administration directly spotlighting MBAI.c and MedMatrix

Today, MedBright AI (MBAI.c MBAIF) announced that a Southern California clinic has adopted MedMatrix AI Market Expander to launch the opening of its new clinic location: https://financialpost.com/globe-newswire/southern-california-clinic-uses-medmatrix-ai-market-expander-to-launch-opening-of-new-clinic-locations

Within the $1.37 trillion projected outpatient clinical services market, ($729 billion in the US alone), MBAI.c offers adaptive pricing & revenue-sharing for its MedMatrix Platform, looking to disrupt the global healthcare sector w/ its cutting-edge AI technology.

Must-watch video titled 'The Cure for Cancer Is... Artificial Intelligence?' on how artificial intelligence can revolutionize the healthcare industry:

It highlights MedBright AI (MBAI.c MBAIF) who is revolutionizing a US$726 Billion Market Opportunity in the healthcare space with artificial intelligence through its MedMatrix AI Product Suite

MBAI has unveiled revenue-linked pricing for its MedMatrix AI Platform for outpatient clinics. The post below highlights MedMatrix's advanced AI infrastructure, timely launch amidst the outpatient clinical services market's growth to $729B & how it is positioned to disrupt healthcare tech landscape.

https://www.reddit.com/r/Baystreetbets/comments/1b98utg/revolutionizing_outpatient_clinical_services/?utm_source=share&utm_medium=web2x&context=3

With advanced AI infrastructure, MBAI's MedMatrix Platform optimizes clinic operations, aligning with market growth. + MBAI's revenue-sharing pricing model for MedMatrix underscores their commitment to client success.
https://www.medbright.ai/blog-posts/medmatrix-go-to-market-pricing-announced-for-ai-product-suite-addressing-us-726-billion-market

MBAI.c unveils pricing for MedMatrix, a multifunction AI platform for healthcare clinics, offering flexible pricing tied to client success and increased revenue, reflecting a commitment to value delivery. MBAI is looking to reshape outpatient services globally, targeting a $726 billion market.

Details + analysis here⬇️
https://www.reddit.com/r/Pennystocksv2/comments/1b7l07z/unleashing_the_potential_of_ai_in_healthcare/

MBAI unveiled its AI Health-Tech Platform's go-to-market pricing today. Looks like they are going to use a revenue-sharing model which should be appealing to potential customers & shows confidence in their ability to increase clinic revenue. Addressable market = US$726 Billion
https://www.medbright.ai/blog-posts/medmatrix-go-to-market-pricing-announced-for-ai-product-suite-addressing-us-726-billion-market

Addressing a US$726 billion market, MBAI announced the go-to-market pricing for its MedMatrix AI product suite which is being moved to full commercialization - based on the established and substantial scalability as well as the vast addressable market, MBAI could see easy multiples here: https://www.medbright.ai/blog-posts/medmatrix-go-to-market-pricing-announced-for-ai-product-suite-addressing-us-726-billion-market

MedBright AI Investments Inc. has completed beta testing for its AI health-tech platform, MedMatrix & is transitioning into revenue generation. With features aimed at optimizing clinic operations and driving revenue growth, Medmatrix is expected to increase clinic revenue by 10% w/ no extra clinic expenditures
https://www.globenewswire.com/news-release/2024/02/27/2835946/0/en/MedMatrix-Product-Moves-from-Beta-to-Full-Commercialization-Announces-AI-Product-Suite.html

Beta testing for MBAI.c's MedMatrix AI Health-tech Platform has concluded & its full commercialization is imminent. MGMT is preparing to launch a revenue-generating strategy & has chosen a 5-feature product suite for MedMatrix to sell into the global health clinic/hospital market. MBAI up 6% today.

Breakdown here: https://www.reddit.com/r/Wealthsimple_Penny/comments/1b3eny8/medbrights_mbaic_medmatrix_ai_platform_unveiling/?utm_source=share&utm_medium=web2x&context=3

New interview with MedBright AI (MBAI.c MBAIF) CEO Trevor Vieweg from PennyQueen regarding the completion of MedMatrix's Beta testing and the AI Data Analytics Platform's movement to full commercialization with an AI product suite:

Beta testing for MBAI's MedMatrix platform is officially over + they've unveiled some more AI features for outpatient clinics. MedMatrix is poised for full commercialization & MBAI is getting ready to unveil its revenue-generating go-to-market strategy.
https://www.globenewswire.com/news-release/2024/02/27/2835946/0/en/MedMatrix-Product-Moves-from-Beta-to-Full-Commercialization-Announces-AI-Product-Suite.html

Given its substantial scalability and vast addressable market, MedBright AI (MBAI.c MBAIF) could be seeing easy multiples now that it's moving toward commercialization for its MedMatrix AI Data Analytics Platform: https://www.reddit.com/r/Canadapennystocks/comments/1b1gsht/today_medbright_ai_mbaic_mbaif_announces/

Yesterday, MBAI revealed that its MedMatrix AI Platform has concluded beta testing w/ inaugural clients, closing up on high volume as a result. W/ this MedMatrix is moving from beta to full-commercialization & a go-to-market strategy is in the works. MBAI's beta customers, including a Yale School of Medicine Affiliated Clinic Group, are expected to be transitioned to MedMatrix's full version. Breakdown here⬇️
https://www.reddit.com/r/smallstreetbets/comments/1b1s0ck/revolutionizing_outpatient_healthcare_with_ai/

Today, MBAI announced that its MedMatrix AI-Platform has completed beta testing and is transitioning into full-commercialization. Despite

Big news from MedBright AI (MBAI.c MBAIF) today, announcing the completion of its beta testing for MedMatrix and movement of the AI data analytics platform to full commercialization with an AI product suite - could see easy multiples here given its substantial scalability and vast addressable market: https://www.globenewswire.com/news-release/2024/02/27/2835946/0/en/MedMatrix-Product-Moves-from-Beta-to-Full-Commercialization-Announces-AI-Product-Suite.html

Another new platform launch for MBAI. The health-tech company's Limmi Disease Insights Platform is set to be used at UC San Diego's Hospital to enhance the identification of recurring kidney stone disease. More in this post: https://www.reddit.com/r/Wallstreetbetsnew/comments/1axl16h/today_medbright_ai_mbaic_launches_limmi_disease/

Yesterday, MBAI.c launched its Limmi Disease Insights AI Platform at UC San Diego to aid in kidney stone detection. MBAI already secured 14 partner clinics for its main AI platform, MedMatrix, in just 2 months. These developments show that MBAI can quickly scale & expand its client base. Breakdown⬇️
https://www.reddit.com/r/Wallstreetbetsnew/comments/1axl16h/today_medbright_ai_mbaic_launches_limmi_disease/

Today, MBAI announced the implementation of its Limmi Disease Insights Platform at UC San Diego's University Hospital to improve the detection of kidney stone disease recurrence
https://www.globenewswire.com/news-release/2024/02/22/2833631/0/en/MedBright-AI-Announces-Limmi-Disease-Insights-Platform-Being-Used-in-University-Hospital-Setting-to-Improve-Detection-of-Kidney-Stone-Disease-Recurrence.html

MedBright AI (MBAI.c MBAIF) continuing its expansion, announcing today that is Limmi Disease Insights Platform is now being used in hospitals to improve the detection of kidney stone disease recurrence: https://www.globenewswire.com/news-release/2024/02/22/2833631/0/en/MedBright-AI-Announces-Limmi-Disease-Insights-Platform-Being-Used-in-University-Hospital-Setting-to-Improve-Detection-of-Kidney-Stone-Disease-Recurrence.html

This AI platform provider caught my eye with over 3x the average volume today - it's aiming to drive innovation in healthcare with its focus on a $200 billion dollar healthcare problem of congested waiting room: https://www.reddit.com/r/PennyStocksCanada/comments/1awl76e/ai_platform_provider_targeting_a_200b_healthcare/

On the heels of demonstrating the substantial scalability & size of the addressable market for its AI platform, MedBright AI (MBAI.c MBAIF) secured significant financing with the closure of a LIFE offering for gross proceeds of $1.4M: https://www.reddit.com/r/PennyStocksCanada/comments/1apc2ov/medbright_ai_mbaic_mbaif_closes_14m_offering/

MBAI.c is expanding the capabilities of its AI platform. Lots of details/analysis in this post which highlights how this move show's the scalability of MBAI's tech.
https://www.reddit.com/r/PennyStocksCanada/comments/1am9bl4/healthtech_investment_firm_medbright_ai_mbaic/

MBAI.c is expanding the capabilities of its MedMatrix AI-platform in partnership with a prestigious dermatology group, demonstrating the scalability and swift deployment capabilities of the platform.
https://www.medbright.ai/blog-posts/medbright-ais-medmatrix-to-expand-its-ai-offerings-for-cosmetic-marketing-clinical-trial-analytics

MBAI's shows how they tackle the healthcare waiting room issue w/ their AI platform. In just 2 months, MBAI.c has on-boarded 14 clinics, including a Yale-affiliated group, benefiting various medical professionals, including 5 Mohs surgeons, across several states & provinces

Informative post here on the global AI in Healthcare Market and its projected growth over the next 8 years. Post then goes into MBAIF’s recent news that Rejuvenation medical group expanded its use of MedMatrix.

https://www.reddit.com/r/PennyStocksCanada/comments/1ajpdeh/global_ai_in_healthcare_market_size_predicted_to/

Highlighting the notable scalability of its tech & expansive addressable market, MedBright AI (MBAI.c MBAIF) recently expanded the uses for its MedMatrix AI Platform: https://www.reddit.com/r/ArtificialInteligence/comments/19e1tv0/today_medbright_ai_mbaic_mbaif_expanded_its/

MedMatrix is an AI-powered data analytics platform which can drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic

This post really shows how MBAI is proving the scalability of their health-tech platform by expanding its capabilities to include data analysis & clinical trial recruitment. Considering MedMatrix is already expected to increase rev @ clinics by 10% w/ no extra cost to clinics (mainly through its patient scheduling capabilities) this expansion could be very appealing to clinics. https://www.reddit.com/r/Baystreetbets/comments/1afxmkm/medbright_ai_mbaic_expands_its_healthtech_ai/

MBAI.c is expanding MedMatrix in collaboration w/ an esteemed dermatology group. This clearly displays the scalability & rapid deployment capabilities of MBAI's platform.
https://www.medbright.ai/blog-posts/medbright-ais-medmatrix-to-expand-its-ai-offerings-for-cosmetic-marketing-clinical-trial-analytics

Short & sweet MBAIF video that highlights the challenges in healthcare waiting rooms & showcases their AI platform's solution to optimize provider schedules. MBAI believes the market opportunity for this tech is $200B👀💰

Good post here on MBAIF and their recent news that medical group Rejuvenation are expanding its use of MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis.

https://www.reddit.com/r/CanadianStocks/comments/1ae4633/medbright_ai_investments_inc_mbaic_mbaif_advances/

MBAI.c up 8% on above-avg vol today. Displaying its swift scalability, MBAI recently announced that it is expanding its MedMatrix AI platform so it can perform data analysis & clinical trial recruitment for the leading dermatology group Rejuvenation. More in this post for anyone interested⬇️
https://www.reddit.com/r/PennyStocksCanada/comments/1ab57um/medbright_ai_investments_mbaic_featured_on_stocks/

Good 'Stocks in Play' article here highlighting how a leading dermatology group is expanding its usage of MBAI's MedMatrix platform to encompass cosmetic treatment marketing, clinical trial recruitment & data analysis across its 8 clinics. This, along with the fact that MBAI (Market Cap

Attesting to the significant scalability of its tech and the size of its addressable market, MedBright AI (MBAI.c MBAIF) recently announced the expansion of uses for MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis: https://www.reddit.com/r/ArtificialInteligence/comments/19e1tv0/today_medbright_ai_mbaic_mbaif_expanded_its/

MBAI has expanded its MedMatrix AI-Platform via a strategic collaboration w/ Rejuvenation, showcasing scalability in its $200B addressable market. Despite a sub-$22M market cap, MBAI secured 14 partner clinics (including a Yale-affiliated group) in just 2 months, indicating fast growth potential
https://www.reddit.com/r/Wallstreetbetsnew/comments/19dz1x8/mbaic_in_the_green_on_high_voltoday_after/

Demonstrating the significant scalability of its tech and the size of the addressable market ($200B), MedBright AI (MBAI.c MBAIF) announced the expansion of its MedMatrix AI platform to include marketing for cosmetic treatments and clinical trial recruitment and data analysis: https://financialpost.com/globe-newswire/medbright-ais-medmatrix-to-expand-its-ai-offerings-for-cosmetic-marketing-clinical-trial-analytics

MBAI is trading in the green on above-average volume after announcing that it is expanding its MedMatrix AI-Health-Tech Platform's collaboration with Rejuvenation, a leading dermatology group. The move enhances cosmetic marketing and clinical trial analytics, elevating patient care and solidifying MedBright's role in healthcare technology investments
https://financialpost.com/globe-newswire/medbright-ais-medmatrix-to-expand-its-ai-offerings-for-cosmetic-marketing-clinical-trial-analytics

This expansion highlights the scalability of MBAI's MedMatrix Platform within the massive 200 billion dollar addressable healthcare market. It also highlights the ability for MBAI to scale the deployment and number of users of their Medmatrix platform rapidly. Despite MBAI's Market Cap being less than 22M they have already signed on 14 clinics within 2 months, (including a Yale School of Medicine Affiliated Clinic Group).

The scalability of this tech and the size of the addressable market means easy multiples here if they can continue to execute on signing up clinics.

MBAI announced its participation at the CEM Bahamas Small-Cap Conference and the upcoming Maxim Group's 2024 Healthcare IT Virtual Conference on Jan 24 at 9 AM ET. Good to hear that the health tech junior is rubbing shoulders with industry leaders & qualified prospective investors.
https://financialpost.com/globe-newswire/medbright-ai-to-present-at-cem-bahamas-small-cap-conference-and-maxim-groups-2024-healthcare-it-conference

Good video here on MBAI.c, a health-tech newcomer addressing the "waiting room problem" with AI, anticipating a 10% revenue boost without extra costs to clinics. Notably, practitioners at several clinics in the US & Canada, including 5 specialized Mohs surgeons, have already embraced the platform.

MBAI will be presenting at both the CEM Bahamas Small-Cap Conference and Maxim Group's 2024 Healthcare IT Conference in the upcoming week: https://www.globenewswire.com/news-release/2024/01/19/2812272/0/en/MedBright-AI-to-Present-at-CEM-Bahamas-Small-Cap-Conference-and-Maxim-Group-s-2024-Healthcare-IT-Conference.html

Marking the achievement of its near-term goal, MedBright AI (MBAI.c MBAIF) announced today that they've reached US$100M in total clinic revenue under contract with MedMatrix: https://financialpost.com/globe-newswire/medbright-ai-reaches-us100m-in-total-clinic-revenue-under-contract-with-medmatrix-the-ai-powered-data-analytics-platform

MedMatrix is an AI-powered data analytics platform which can drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic